Hosseini-Gerami, Layla
Higgins, Ixavier Alonzo
Collier, David A.
Laing, Emma
Evans, David
Broughton, Howard
Bender, Andreas
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/M011194/1, BB/M011194/1)
Eli Lilly and Company (BB/M011194/1, BB/M011194/1)
Article History
Received: 7 January 2022
Accepted: 6 April 2023
First Online: 18 April 2023
Change Date: 3 May 2023
Change Type: Update
Change Details: The author David A. Collier was incorrectly assigned to the affiliation Ignota Labs, London, UK. The article has been updated to rectify the error.
Declarations
:
: CBDD and MetaBase™ are proprietary to Clarivate™, who granted a license to Eli Lilly and Company for access and use. A license can be obtained by visiting.
: Not applicable.
: IAH, DAC, EL, DE and HB are either current employees or were employees of Eli Lilly and Company during the time the project took place. No competing interests are declared by LH-G or AB.